Nature Communications (Aug 2019)

S100A9 extends lifespan in insulin deficiency

  • Giorgio Ramadori,
  • Sanda Ljubicic,
  • Serena Ricci,
  • Despoina Mikropoulou,
  • Xavier Brenachot,
  • Christelle Veyrat-Durebex,
  • Ebru Aras,
  • Rafael M. Ioris,
  • Jordi Altirriba,
  • Elisabeth Malle,
  • Dirk Foell,
  • Thomas Vogl,
  • Roberto Coppari

DOI
https://doi.org/10.1038/s41467-019-11498-x
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 12

Abstract

Read online

Insulin replacement is a valuable therapy for insulin deficiency, however, other therapies are being investigated to restore metabolic homeostasis. Here, the authors identify S100A9 as a leptin induced circulating cue that improves glucose and lipid homeostasis and extends survival in insulin deficient mice.